CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shenzhen Neptunus Bioengineering Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shenzhen Neptunus Bioengineering Co Ltd
24F, Neptunus Galaxy Technology Mansion,
Phone: +86 75526980336p:+86 75526980336 SHENZHEN, GNG  518057  China Ticker: 000078000078
Business Summary
Shenzhen Neptunus Bioengineering Co Ltd is a China-based company primarily engaged in the pharmaceutical research and development, pharmaceutical manufacturing, and pharmaceutical commercial circulation. The Company mainly operates three businesses. The pharmaceutical commercial business is engaged in providing downstream customers such as medical institutions, drug retail institutions, and distributors with distribution and related extended value-added services for medical supplies such as drugs and medical devices. The pharmaceutical industry business is engaged in the research and development, production, and sales of large infusion products, western medicine preparations and others. The pharmaceutical research and development business is engaged in the research of innovative drugs and generic drugs. The Company mainly conducts its business in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202512/31/2024Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
5047 Medical, dental, and hospital equipment and supplies
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2099 Food preparations, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board SiminZhang 63 12/13/1992 12/13/1992
President, Vice Chairman of the Board FengZhang 53 10/14/2019 9/1/2001
Chief Financial Officer, Vice President, Director DakaiShen 60 10/31/2022 5/26/2006
10 additional Officers and Directors records available in full report.

Business Names
Business Name
000078
Shenzhen Neptunus Bioengineering Co. Ltd

General Information
Number of Employees: 9,093 (As of 12/31/2023)
Outstanding Shares: 2,631,123,257 (As of 3/31/2025)
Shareholders: 140,122
Stock Exchange: SHE
Fax Number: +86 75526968995


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 11, 2025